Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Sam Behjati(University of Cambridge), Patrick Tarpey(Wellcome Sanger Institute), Nadège Presneau(Sarah Cannon Research Institute), Susanne Scheipl(University of Graz), Nischalan Pillay(Royal National Orthopaedic Hospital), Peter Van Loo(Wellcome Sanger Institute), David C. Wedge(Wellcome Sanger Institute), Susanna L. Cooke(Wellcome Sanger Institute), Gunes Gundem(Wellcome Sanger Institute), Helen Davies(Wellcome Sanger Institute), Serena Nik‐Zainal(Wellcome Sanger Institute), Sancha Martin(Wellcome Sanger Institute), Stuart McLaren(Wellcome Sanger Institute), Victoria Goody(Wellcome Sanger Institute), Ben Robinson(Wellcome Sanger Institute), Adam Butler(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Dina Halai(National Health Service), Bhavisha Khatri(National Health Service), Ola Myklebost(Oslo University Hospital), Daniel Baumhoer(University Hospital of Basel), Gernot Jundt(University Hospital of Basel), Rifat Hamoudi(Sarah Cannon Research Institute), Roberto Tirabosco(National Health Service), Maria Fernanda Amary(National Health Service), P. Andrew Futreal(Wellcome Sanger Institute), Michael R. Stratton(Wellcome Sanger Institute), Peter J. Campbell(University of Cambridge), Adrienne M. Flanagan(National Health Service)
Cited by 851Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis